Intervention

Sulfamethoxazole

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions3

Lead sponsors shown4

Clinical trials

4 shown

Islet Transplantation for Type 1 DiabetesNCT00014911 · 2001-04-01

A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSNCT00002283

A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency SyndromeNCT00002002

Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii PneumoniaNCT00002120

Common conditions

HIV Infections3 Pneumonia, Pneumocystis Carinii3 Diabetes Mellitus, Insulin-Dependent1

Leading sponsors

Jacobus Pharmaceutical1 Lederle Laboratories1 National Institute of Allergy and Infectious Diseases (NIAID)1 U.S. Bioscience1

Trial status mix

COMPLETED4

Phase mix

NA2

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.